Minnesota Department of Health Fact Sheet[removed]Smoking-Attributable Mortality and Economic Costs in Minnesota

First Page		Document Content
Date: 2013-10-09 16:19:21 Medicine Human anatomy Respiratory disease Cardiovascular disease Bronchitis Chronic Bronchus Hypertension Emphysema Chronic lower respiratory diseases Respiratory system Smoking		Minnesota Department of Health Fact Sheet[removed]Smoking-Attributable Mortality and Economic Costs in Minnesota Add to Reading List Source URL: www.health.state.mn.us Download Document from Source Website File Size: 130,02 KB Share Document on Facebook

	Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality Please note, this report is designed for double-sided printing DocID: 1rXbZ - View Document
	BMS_2016_Inflammation_emphysema_Fibrosis_2016.pdf DocID: 1nVzq - View Document
	Pulmonx Gets FDA Nod for U.S. Trial of Emphysema Therapy IDE for Study of Zephyr® Endobronchial Valve Approved August 27, 2012, Redwood City, CA, USA, Pulmonx, an emerging leader in interventional pulmonology, announced DocID: 1lQgn - View Document
	Treatment Options Literature 1. Sciurba F et al. A randomized study of endobronchial valves for advanced emphysema. N Eng J Med 2010;363:. Felix J.F. Herth, Marc Noppen, Arschang Valipour, Sylvie Leroy,Jean-M DocID: 1lEMB - View Document
	Patient Guide PCEN12/11_01 Endobronchial Valve Treatment of Emphysema Patients DocID: 1llqd - View Document